Vitrolife Group
Chris Nicol is an experienced electrical engineer currently employed at SMART Technologies since July 2010, contributing to the development of hardware for innovative DViT interactive whiteboards and educational devices. Previously, Chris served as a firmware engineer, where responsibilities included developing firmware and diagnostic tools for similar products. Prior experience includes electronics contracting for the Science Alberta Foundation, focusing on educational device design and repair, as well as a teaching assistant role at the University of Calgary. Earlier work at Grindcom involved electronic engineering tasks such as circuit design and software development for forestry control systems. Chris holds an M.Sc. in Electrical Engineering from the University of Calgary and a B.Tech. in Electronics Engineering from DeVry Institute of Technology.
This person is not in any teams
This person is not in any offices
Vitrolife Group
The Vitrolife Group is a world-leading global provider of medical devices and genetic testing services. Dedicated to the reproductive-health market since 1994, we have grown by focusing on product development, groundbreaking research, consistent quality control and acquisitions of innovative companies in the industry. In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services primarly for IVF clinics. Together we are now the Vitrolife Group, a global leader in reproductive health focused on supporting our customers and patients worldwide to improve treatment outcomes – always with sustainability in mind. Based on science and advanced research capabilities, our aim is to deliver products and services for the entire reproductive-health journey, providing consistent performance and guaranteed quality. Currently, we are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our products and services are available in more than 125 countries, through our own presence in more than 25 countries and a vast network of distributors for the rest of the world. We are on a mission to be the leading global partner in reproductive health, striving for better treatment outcomes for patients.